These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30641949)

  • 41. Presynaptic enzymatic neurotoxins.
    Rossetto O; Morbiato L; Caccin P; Rigoni M; Montecucco C
    J Neurochem; 2006 Jun; 97(6):1534-45. PubMed ID: 16805767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serological identification of botulinum neurotoxins: A critical overview.
    Giménez DF
    Anaerobe; 2016 Aug; 40():28-30. PubMed ID: 27130373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell biology. Progress by poisoning.
    Cutler D
    Nature; 1992 Oct; 359(6398):773. PubMed ID: 1436051
    [No Abstract]   [Full Text] [Related]  

  • 44. Novel Native and Engineered Botulinum Neurotoxins.
    Steward L; Brin MF; Brideau-Andersen A
    Handb Exp Pharmacol; 2021; 263():63-89. PubMed ID: 32274579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins.
    Collins MD; East AK
    J Appl Microbiol; 1998 Jan; 84(1):5-17. PubMed ID: 15244052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinal neurotoxins: revival of an old killer.
    Montecucco C; Molgó J
    Curr Opin Pharmacol; 2005 Jun; 5(3):274-9. PubMed ID: 15907915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes.
    Hill KK; Smith TJ
    Curr Top Microbiol Immunol; 2013; 364():1-20. PubMed ID: 23239346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
    Kroken AR; Blum FC; Zuverink M; Barbieri JT
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum neurotoxin: a marvel of protein design.
    Montal M
    Annu Rev Biochem; 2010; 79():591-617. PubMed ID: 20233039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test.
    Weisemann J; Krez N; Fiebig U; Worbs S; Skiba M; Endermann T; Dorner MB; Bergström T; Muñoz A; Zegers I; Müller C; Jenkinson SP; Avondet MA; Delbrassinne L; Denayer S; Zeleny R; Schimmel H; Åstot C; Dorner BG; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):5035-54. PubMed ID: 26703728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics.
    Duchesne de Lamotte J; Perrier A; Martinat C; Nicoleau C
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum Neurotoxins: Still a Privilege of Clostridia?
    Popoff MR
    Cell Host Microbe; 2018 Feb; 23(2):145-146. PubMed ID: 29447689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The travel diaries of tetanus and botulinum neurotoxins.
    Surana S; Tosolini AP; Meyer IFG; Fellows AD; Novoselov SS; Schiavo G
    Toxicon; 2018 Jun; 147():58-67. PubMed ID: 29031941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins.
    Azarnia Tehran D; Zanetti G; Leka O; Lista F; Fillo S; Binz T; Shone CC; Rossetto O; Montecucco C; Paradisi C; Mattarei A; Pirazzini M
    Sci Rep; 2015 Dec; 5():17513. PubMed ID: 26670952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An innovative molecular detection tool for tracking and tracing Clostridium botulinum types A, B, E, F and other botulinum neurotoxin producing Clostridia based on the GeneDisc cycler.
    Fach P; Fenicia L; Knutsson R; Wielinga PR; Anniballi F; Delibato E; Auricchio B; Woudstra C; Agren J; Segerman B; de Medici D; van Rotterdam BJ
    Int J Food Microbiol; 2011 Mar; 145 Suppl 1():S145-51. PubMed ID: 20471128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.
    Pirazzini M; Rossetto O; Eleopra R; Montecucco C
    Pharmacol Rev; 2017 Apr; 69(2):200-235. PubMed ID: 28356439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Botulism: the agent, mode of action of the botulinum neurotoxins, forms of acquisition, treatment and prevention].
    Marvaud JC; Raffestin S; Popoff MR
    C R Biol; 2002 Aug; 325(8):863-78; discussion 879-83. PubMed ID: 12391898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.